Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study

Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study

(2020) Sergio Salgüero et al.   Scientific Reports

Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges

(2019) Sirina Ekpanyapong et al.   United European Gastroenterology Journal

Effectiveness of direct‐acting agents for hepatitis C and liver stiffness changing after sustained virological response

(2019) Flavia F Fernandes et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

(2019) Yu-Chi Lee et al.   PLoS One

Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

(2019) Tea Lund Laursen et al.   JOURNAL OF VIRAL HEPATITIS

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

(2018) Luz M. Medrano et al.   AIDS

Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection

(2018) Omar El-Sherif et al.   GASTROENTEROLOGY

Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals

(2018) Francesca Faillaci et al.   HEPATOLOGY

Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population

(2018) Cameron Sikavi et al.   HEPATOLOGY

Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients

(2018) Luis F López-Cortés et al.   JOURNAL OF INFECTIOUS DISEASES

Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in “special populations”

(2018) Stanislas Pol et al.   LIVER INTERNATIONAL

Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C

(2018) Geórgia Nascimento Saraiva et al.   MEDIATORS OF INFLAMMATION

Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment

(2018) Saverio G. Parisi et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection

(2018) Gema M. Lledó et al.   AIDS

A changing paradigm: management and treatment of the HCV/HIV-co-infected patient

(2018) Ameer Abutaleb et al.   Hepatology International

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

(2018) Juan Macías et al.   JOURNAL OF VIRAL HEPATITIS

Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis

(2018) Francesca Romana Ponziani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients

(2018) Barbara Lattanzi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Role of Angiogenesis in Hepatocellular Carcinoma

(2018) Michael A. Morse et al.   CLINICAL CANCER RESEARCH

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

(2018) Ivan Gentile et al.   Hepatology International

Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy

(2018) Hu Li et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis

(2017) Sabela Lens et al.   GASTROENTEROLOGY

Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection

(2017) Juan Berenguer et al.   HEPATOLOGY

Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients

(2017) Jordi Navarro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR

(2017) C. Carlton-Smith et al.   JOURNAL OF VIRAL HEPATITIS

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension

(2017) N. Afdhal et al.   JOURNAL OF VIRAL HEPATITIS

Mechanisms of hepatic stellate cell activation

(2017) Takuma Tsuchida et al.   Nature Reviews Gastroenterology & Hepatology

Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients

(2017) Saeid Najafi Fard et al.   Clinics and Research in Hepatology and Gastroenterology

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

(2017) Hsiao-Ching Nien et al.   PLoS One

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon

(2017) Claudia Mascia et al.   PLoS One

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

(2016) P. Schwabl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

(2016) Mattias Mandorfer et al.   JOURNAL OF HEPATOLOGY

Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection

(2016) Peter W. Hunt et al.   JOURNAL OF INFECTIOUS DISEASES

Global epidemiology and burden of HCV infection and HCV-related disease

(2016) Aaron P. Thrift et al.   Nature Reviews Gastroenterology & Hepatology

DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment

(2016) Rosanna Villani et al.   PLoS One

Thrombin activation and liver inflammation in advanced hepatitis C virus infection

(2016) Emilio González-Reimers   WORLD JOURNAL OF GASTROENTEROLOGY

The Statistical Value of Raw Fluorescence Signal in Luminex xMAP Based Multiplex Immunoassays

(2016) Edmond J. Breen et al.   Scientific Reports

Molecular pathophysiology of portal hypertension

(2015) Mercedes Fernandez   HEPATOLOGY

Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients

(2014) Vincent Lo Re et al.   ANNALS OF INTERNAL MEDICINE

Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

(2014) Agustín Albillos et al.   JOURNAL OF HEPATOLOGY

HCV and HIV co-infection: mechanisms and management

(2014) Jennifer Y. Chen et al.   Nature Reviews Gastroenterology & Hepatology

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

(2012) J. Berenguer et al.   CLINICAL INFECTIOUS DISEASES

Cytokine Levels and Histopathology in Chronic Hepatitis B and Chronic Hepatitis C

(2012) Fusun Zeynep Akcam et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis

(2012) Diego Rincón et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Soluble biomarkers of HIV transmission, disease progression and comorbidities

(2012) Edwin Leeansyah et al.   Current Opinion in HIV and AIDS